These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
809 related articles for article (PubMed ID: 31412350)
1. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare. Marembo T; Dube Mandishora R; Borok M Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350 [TBL] [Abstract][Full Text] [Related]
2. Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping. Dube Mandishora RS; Rounge TB; Fitzpatrick M; Christiansen IK; Ambur OH; Lagström S; Stray-Pedersen B; Tommasino M; Palefsky J; Chirenje ZM PLoS One; 2021; 16(4):e0250426. PubMed ID: 33901223 [TBL] [Abstract][Full Text] [Related]
3. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples. Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441 [TBL] [Abstract][Full Text] [Related]
4. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe. Dube Mandishora RS; Christiansen IK; Chin'ombe N; Duri K; Ngara B; Rounge TB; Meisal R; Ambur OH; Palefsky JM; Stray-Pedersen B; Chirenje ZM J Med Virol; 2017 Sep; 89(9):1671-1677. PubMed ID: 28390142 [TBL] [Abstract][Full Text] [Related]
5. High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women. Kuguyo O; Dube Mandishora RS; Thomford NE; Makunike-Mutasa R; Nhachi CFB; Matimba A; Dandara C PLoS One; 2021; 16(9):e0257324. PubMed ID: 34582476 [TBL] [Abstract][Full Text] [Related]
6. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study. Sun P; Song Y; Ruan G; Mao X; Kang Y; Dong B; Lin F J Gynecol Oncol; 2017 Sep; 28(5):e50. PubMed ID: 28657218 [TBL] [Abstract][Full Text] [Related]
7. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up. Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana. Tawe L; MacDuffie E; Narasimhamurthy M; Wang Q; Gaseitsiwe S; Moyo S; Kasvosve I; Shin SS; Zetola NM; Paganotti GM; Grover S Int J Cancer; 2020 Mar; 146(6):1667-1673. PubMed ID: 31325316 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana. Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844 [TBL] [Abstract][Full Text] [Related]
10. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology. Ali MAM; Bedair RN; Abd El Atti RM Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155 [TBL] [Abstract][Full Text] [Related]
11. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia. Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G; J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892 [TBL] [Abstract][Full Text] [Related]
13. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors. Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059 [TBL] [Abstract][Full Text] [Related]
14. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women. Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville). Boumba LM; Qmichou Z; Mouallif M; Attaleb M; El Mzibri M; Hilali L; Donatien M; Ennaji MM J Med Virol; 2015 Oct; 87(10):1769-76. PubMed ID: 25963674 [TBL] [Abstract][Full Text] [Related]
16. Genotypic distribution of human oncogenic papillomaviruses in sexually active women in Burkina Faso: Central, Central-Eastern and Hauts-Bassins regions. Ouedraogo RA; Zohoncon TM; Traore IMA; Ouattara AK; Guigma SP; Djigma FW; Obiri-Yeboah D; Ouedraogo C; Simpore J Biomol Concepts; 2020 May; 11(1):125-136. PubMed ID: 32417758 [TBL] [Abstract][Full Text] [Related]
17. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions. Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. Munoz M; Camargo M; Soto-De Leon SC; Sanchez R; Parra D; Pineda AC; Sussmann O; Perez-Prados A; Patarroyo ME; Patarroyo MA PLoS One; 2013; 8(2):e56509. PubMed ID: 23418581 [TBL] [Abstract][Full Text] [Related]
19. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. Couture MC; Page K; Stein ES; Sansothy N; Sichan K; Kaldor J; Evans JL; Maher L; Palefsky J BMC Infect Dis; 2012 Jul; 12():166. PubMed ID: 22839728 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019. Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]